Leading innovator in drug development brings more than three decades of biotechnology and pharmaceutical experience to the company’s Board of Directors August 23, 2017 05:00 AM Pacific Daylight Time PLEASANTON, Calif.–(BUSINESS WIRE)–10x Genomics, a company focused on enabling the mastery of biology by accelerating genomic discovery, today announced that Mathai Mammen, M.D., Ph.D. has been... Read more
Decades-Long Track Record of Corporate Counsel and Establishing/Protecting Intellectual Property Across the Technology Landscape August 16, 2017 05:00 AM Pacific Daylight Time PLEASANTON, Calif.–(BUSINESS WIRE)–10x Genomics, a company focused on enabling the mastery of biology by accelerating genomic discovery, today announced the appointment of Eric Whitaker as general counsel. In this role, Whitaker will serve as... Read more
– The Chromium™ Single Cell V(D)J Solution enables the scalable identification of paired T-cell transcripts from hundreds to millions of lymphocytes, an essential capability for immunotherapy development and proliferation – PLEASANTON, Calif. – March 27, 2017 – 10x Genomics, a company focused on enabling the mastery of biology by accelerating genomic discovery, today announced the... Read more
PLEASANTON, Calif. – February 9, 2017 – 10x Genomics, a company focused on enabling the mastery of biology by accelerating genomic discovery, today announced the appointment of Bradford J. Crutchfield as chief commercial officer of the company. Mr. Crutchfield will oversee global sales, marketing, business development and customer support. John Pouk, the company’s interim chief... Read more
Combines award-winning Chromium™ System from 10x Genomics with PerkinElmer’s state-of-the-art automation solutions PLEASANTON, Calif., January 9, 2017 – 10x Genomics, Inc., a company focused on enabling the mastery of biology by accelerating genomic discovery, today announced they and PerkinElmer, Inc. will jointly offer automated next-generation sequencing (NGS) solutions. PerkinElmer’s automation solutions increase both the throughput... Read more
U.S. Patent and Trademark Office finds U.S. Patent No. 8,658,430 invalid in inter partes review PLEASANTON, Calif., January 20, 2017 – 10x Genomics, Inc. today announced that the company has prevailed in an inter partes review proceeding before the U.S. Patent and Trademark Office to invalidate U.S. Patent No. 8,658,430 owned by RainDance Technologies, Inc.... Read more
–Philibert will focus on cultivating a culture of innovation and excellence for 10x Genomics employees worldwide– PLEASANTON, CA.—June 14, 2018—10x Genomics, a company focused on accelerating genomic discovery, today announced that Jean Philibert has joined the company as Chief People Officer. She brings almost 20 years experience in leading human resources for companies in software... Read more